DSI
Daiwa SB Investments Portfolio holdings
AUM
$506M
This Quarter Return
+5.13%
1 Year Return
+11%
3 Year Return
+60.61%
5 Year Return
+93.25%
10 Year Return
–
AUM
$366M
AUM Growth
+$366M
(-1.7%)
Cap. Flow
-$21.2M
Cap. Flow
% of AUM
-5.8%
Top 10 Holdings %
Top 10 Hldgs %
36.31%
Holding
260
New
16
Increased
47
Reduced
158
Closed
18
Top Buys
| 1 |
Coca-Cola
KO
|
$5.83M |
| 2 |
NetEase
NTES
|
$1.68M |
| 3 |
JD.com
JD
|
$1.46M |
| 4 |
NVIDIA
NVDA
|
$900K |
| 5 |
Laureate Education
LAUR
|
$870K |
Top Sells
| 1 |
Toronto Dominion Bank
TD
|
$7.11M |
| 2 |
Starbucks
SBUX
|
$5.65M |
| 3 |
Schlumberger
SLB
|
$3.93M |
| 4 |
Alibaba
BABA
|
$2.25M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$1.13M |
Sector Composition
| 1 | Technology | 16.61% |
| 2 | Consumer Discretionary | 15.37% |
| 3 | Consumer Staples | 10.67% |
| 4 | Healthcare | 10.33% |
| 5 | Financials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Realty Income
O
$52.8B
| $118K | 0.03% |
2,140
-260
| -11% | -$14.3K |
|
152
Tyson Foods
TSN
$20.1B
| $118K | 0.03% |
1,880
-280
| -13% | -$17.6K |
|
|
ALDR
153
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $117K | 0.03% |
10,255
-100
| -1% | -$1.14K |
|
154
LyondellBasell Industries
LYB
$18B
| $116K | 0.03% |
1,370
-220
| -14% | -$18.6K |
|
|
ANDV
155
DELISTED
Andeavor
ANDV
| $113K | 0.03% |
1,210
-200
| -14% | -$18.7K |
|
156
Fidelity National Information Services
FIS
$35.7B
| $110K | 0.03% |
1,290
-140
| -10% | -$11.9K |
|
157
CGI
GIB
$21.5B
| $106K | 0.03% |
2,080
-330
| -14% | -$16.8K |
|
158
Thomson Reuters
TRI
$80.1B
| $105K | 0.03% |
2,260
-360
| -14% | -$16.7K |
|
|
AIMT
159
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $104K | 0.03% |
5,045
-1,050
| -17% | -$21.6K |
|
160
Assurant
AIZ
$10.8B
| $95K | 0.03% |
920
-150
| -14% | -$15.5K |
|
161
TE Connectivity
TEL
$60.4B
| $92K | 0.03% |
1,170
-190
| -14% | -$14.9K |
|
|
GBT
162
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $92K | 0.03% |
3,358
+108
| +3% | +$2.96K |
|
163
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$4.59B
| $90K | 0.02% |
1,630
+420
| +35% | +$23.2K |
|
164
Neurocrine Biosciences
NBIX
$14.1B
| $90K | 0.02% |
+1,954
| New | +$90K |
|
165
Synchrony
SYF
$28.1B
| $89K | 0.02% |
2,990
-480
| -14% | -$14.3K |
|
166
Bunge Global
BG
$16.3B
| $87K | 0.02% |
1,160
-190
| -14% | -$14.3K |
|
|
MYOK
167
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $82K | 0.02% |
6,240
-6,725
| -52% | -$88.4K |
|
|
DRE
168
DELISTED
Duke Realty Corp.
DRE
| $81K | 0.02% |
2,890
-1,030
| -26% | -$28.9K |
|
169
L3Harris
LHX
$51.5B
| $80K | 0.02% |
730
-70
| -9% | -$7.67K |
|
|
AET
170
DELISTED
Aetna Inc
AET
| $79K | 0.02% |
520
-40
| -7% | -$6.08K |
|
171
Agnico Eagle Mines
AEM
$74.2B
| $78K | 0.02% |
+1,730
| New | +$78K |
|
|
TRVN
172
DELISTED
Trevena, Inc.
TRVN
| $78K | 0.02% |
33,960
-500
| -1% | -$1.15K |
|
173
Goodyear
GT
$2.4B
| $76K | 0.02% |
2,170
-340
| -14% | -$11.9K |
|
174
AbbVie
ABBV
$374B
| $69K | 0.02% |
+950
| New | +$69K |
|
175
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $69K | 0.02% |
1,370
+320
| +30% | +$16.1K |
|